Novacap completes the acquisition of PCI Synthesis and expands its pharmaceutical offerings in the U.S.
28. Juni 2018 12:01 ET
|
PCI Synthesis; Novacap
LYON, France and NEWBURYPORT, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has completed the...
Novacap to expand its pharmaceutical offering in the U.S. with the acquisition of PCI Synthesis
20. Juni 2018 12:03 ET
|
PCI Synthesis; Novacap
LYON, France and NEWBURYPORT, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an...
PCI Synthesis Celebrates Key Milestones Including 4th Consecutive Year of Double-Digit Growth, 2 Commercial Approvals and a New Office in San Diego
27. Februar 2018 09:15 ET
|
PCI Synthesis
NEWBURYPORT, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEis), generic active pharmaceutical...
PCI Synthesis Submits Patent for Synthesizing Azelaic Acid
30. Januar 2018 09:15 ET
|
PCI Synthesis
NEWBURYPORT, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
PCI Synthesis’ Ed Price Joins SOCMA’s Board of Governors
11. Januar 2018 09:15 ET
|
PCI Synthesis
NEWBURYPORT, Mass., Jan. 11, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2018
18. Dezember 2017 09:15 ET
|
PCI Synthesis
NEWBURYPORT, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
Scott VanderWel Joins PCI Synthesis as Business Development Manager
15. November 2017 10:15 ET
|
PCI Synthesis
NEWBURYPORT, Mass., Nov. 15, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
PCI Synthesis Wins Big at 2017 Life Science Leader Magazine CMO Leadership Awards
23. März 2017 09:14 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Mar 23, 2017) - PCI Synthesis, Inc., a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other...
PCI Synthesis picks up Life Science CMO Leaderships Awards in all six categories
01. Februar 2017 09:11 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Feb 1, 2017) - PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients...
PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2017
19. Dezember 2016 09:16 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Dec 19, 2016) - PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients...